Position in OPTH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,694
New position
Shares Held
333
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $9,797,111 across 23 Drug Manufacturers - Specialty & Generic names. OPTH ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
186,889 | $6,331,799 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
16,691 | $1,067,389 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
30,882 | $760,006 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,228 | $665,367 | |
| 5 | ZTS |
Zoetis Inc.
|
4,885 | $351,036 | |
| 6 | VTRS |
Viatris Inc
|
8,303 | $131,851 | |
| 7 | HLN |
Haleon plc
|
13,071 | $121,952 | |
| 8 | CGC |
Canopy Growth Corp
|
127,191 | $120,831 |
All Filings in OPTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,694 | 333 | Shares | Defined | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||